Vaccine Market – MENA
Market Statistics
Base Year: 2023
Historical Years: 2018-2023
Forecast Years: 2024-2032
Market Growth Rate: 3.4% (2024-2032)
The MENA vaccine market is expanding due to increasing immunization programs, rising awareness, and government initiatives aimed at enhancing public health. According to the latest report by IMARC Group, the market is projected to grow at a CAGR of 3.4% from 2024 to 2032.
Download sample copy of the Report: https://www.imarcgroup.com/mena-vaccine-market/requestsample
MENA Vaccine Market Trends and Drivers
- Government Initiatives for Immunization:
- Rising government-led initiatives for immunization are significantly contributing to the growth of the MENA vaccine market.
- Increased Healthcare Expenditure:
- Higher healthcare spending in MENA countries is supporting the expansion of vaccine programs and infrastructure.
- Focus on Disease Prevention:
- A heightened emphasis on disease prevention is driving the need for vaccination, particularly to address diseases like hepatitis and influenza.
- Pandemic Impact:
- The COVID-19 pandemic highlighted the importance of resilient healthcare systems, prompting governments to improve vaccine storage and distribution capabilities.
- Partnerships with International Health Organizations:
- Collaborations with global health organizations and vaccine manufacturers have increased the supply of essential vaccines across the region.
- Public & Private Sector Funding:
- Funding from both public and private sectors has accelerated vaccination rates across various age groups.
- Immunization for Long-term Healthcare Cost Reduction:
- Governments are prioritizing immunization to reduce disease burden and healthcare costs in the long term.
- Drive Towards Vaccine Self-Sufficiency:
- Strong push for vaccine self-sufficiency through partnerships and investments in local pharmaceutical manufacturing, particularly in Saudi Arabia, Egypt, and the UAE.
- Digital Health Technologies:
- The rise of digital health technologies is transforming vaccine distribution and tracking, enabling better management of immunization schedules and ensuring vaccine efficacy.
- Combination Vaccines & Adult Immunization:
- Development of combination vaccines and an increased focus on adult immunization are expanding the vaccine market beyond traditional pediatric use.
- Building Robust Healthcare Systems:
- The region’s efforts to strengthen public health resilience and local manufacturing capabilities are expected to further drive growth in the MENA vaccine market.
MENA Vaccine Industry Segmentation:
The market report offers a comprehensive analysis of the segments, highlighting those with the largest MENA vaccine market share. It includes forecasts for the period 2024-2032 and historical data from 2018-2023 for the following segments.
Product Type Insights:
- Multivalent Vaccine
- Monovalent Vaccine
Treatment Type Insights:
- Preventive Vaccine
- Therapeutic Vaccine
Technology Insights:
- Conjugate Vaccines
- Inactivated and Subunit Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Others
Route of Administration Insights:
- Intramuscular and Subcutaneous Administration
- Oral Administration
- Others
Patient Type Insights:
- Pediatric
- Adult
Indication Insights:
- Bacterial Diseases
- Meningococcal Disease
- Pneumococcal Disease
- Diphtheria/Tetanus/Pertussis (DPT)
- Tuberculosis
- Haemophilus Influenzae (Hib)
- Typhoid
- Others
- Viral Diseases
- Hepatitis
- Influenza
- Human Papillomavirus (HPV)
- Measles/Mumps/Rubella (MMR)
- Rotavirus
- Herpes Zoster
- Varicella
- Japanese Encephalitis
- Rubella
- Polio
- Rabies
- Dengue
- Others
Distribution Channel Insights:
- Hospital Pharmacies
- Retail Pharmacies
- Institutional Sales
- Others
End User Insights:
- Hospitals
- Clinics
- Vaccination Centers
- Academic and Research Institutes
- Others
Country Insights:
- Saudi Arabia
- Turkey
- Israel
- United Arab Emirates
- Egypt
- Iran
- Iraq
- Qatar
- Algeria
- Kuwait
- Morocco
- Oman
- Others
Request for customization: https://www.imarcgroup.com/request?type=report&id=16112&flag=C
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Key highlights of the Report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145